MCL
Clinical trials for MCL explained in plain language.
Never miss a new study
Get alerted when new MCL trials appear
Sign up with your email to follow new studies for MCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: scientists test Next-Gen cell therapy
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy for adults with B-cell lymphoma that has come back or hasn't responded to standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look for early signs that the t…
Matched conditions: MCL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo aims to wipe out lingering cancer cells in aggressive lymphoma
Disease control Not yet recruitingThis study is testing if adding a drug called glofitamab after standard initial treatment can better control a fast-growing type of blood cancer called mantle cell lymphoma (MCL). It is for adults newly diagnosed with a high-risk form of MCL who have not yet started treatment. Th…
Matched conditions: MCL
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC